Latebreaking Abstract Submission is now closed!

(Required browser for Mac users is Firefox)

Key Dates

*Note all efforts are made to send notification by the planned date.

Should there be any delays with the selection process, a revised date will be posted here.

Important Information

At Pain360, in keeping with a holistic 360-degree perspective, we are encouraging poster submissions encompassing every aspect of chronic pain including, but not limited to, pathophysiology, evaluation, diagnosis, treatment, outcomes, practice management, epidemiology, and healthcare delivery systems.

At this upcoming meeting in Vienna we are particularly interested in research on chronic pain mechanisms, neurophysiology and neuroanatomy, regenerative medicine, neuropathic pain, neuromodulation in all forms, and telemedicine in the practice of pain medicine.

When submitting your abstract please select the most appropriate category for your submission: Click here to view the Abstract Topics

All accepted posters must comply with internationally accepted standards for human and animal research and provide evidence of institutional review board approval for human and /or animal studies.

Following Scientific Committee review, poster submissions will be selected for presentation. The top-scoring posters will be invited to present an expanded podium presentation.

Rules for Submission

Please read the submission rules before submitting an abstract.

• Required browser for Mac users is Firefox.
• Abstracts must be submitted online via the website only. ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for Podium or e-Poster presentation. The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Limitations:
  • The same person may submit up to 5 abstracts regardless of presenting author.
  • The same person may serve as presenting author on up to 3 abstracts.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by Monday, 13 September 2021 will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official congress publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy: Abstracts that have been previously presented at another meeting may not be submitted.
• Abstracts must be submitted in good English.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

​Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  – Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: Podium or e-Poster ​presentation
• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
• Abstract text – limited to 250 words including acknowledgements. Please note: word count is affected when tables are included.

• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.

• Abstracts should clearly state:
  Introduction
  Method
  Results
  Conclusions
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline, if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

Abstract Submitters’ Declaration

During abstract submission you will be asked to confirm that you agree to the following:

1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
2. Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
3. The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to PAIN 360 and Kenes International Organizers of Congresses SA and its affiliates (together: the “Organizers“), nor the publication of any such Content by each of the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
4. The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
5. I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
6. I understand that the presenting author must be a registered participant.
7. The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
8. I understand that I must select a specific Theme, Topic and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed.  The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.